Artificial intelligence companies have been a focus of investment in the medical technology sector so far in 2025. Although the number of funding rounds decreased in the first half of the year, AI startups were favored by investors, according to a recent report by PitchBook. For example, earlier this month, Aidoc received $150 million in funding for an AI foundation model.
AI devices have also been the subject of recent acquisitions. In August, Tempus agreed to buy Paige, a company making digital pathology software, for $81 million. More recently, GE Healthcare built out its AI portfolio with the planned acquisition of brain MRI software firm Icometrix.
Read on for recent deals involving AI-enabled medical devices covered by MedTech Dive:
